Industry News
February 3, 2012FDA commish counters industry critics on expert conflict rules
February 3, 2012Scoring winners and losers in Japan pharma M&A bout
February 3, 2012Idenix gets good news on hep C trial, but can't compete with Gilead
February 3, 2012AstraZeneca's R&D chief in China lays out $100M strategy
February 3, 2012Gilead shares surge as hep C drug scores a cure for big patient population
February 3, 2012Threshold, Merck KGaA strike $525M licensing deal for promising cancer drug
February 2, 2012U.S. funding drop threatens San Diego life sciences industry
February 2, 2012Is Lilly betting the farm on its high-stakes Alzheimer's gamble?
February 2, 2012AB soars on promising survival data from Phase II tumor study
February 2, 2012Czechs beef up investment in biotech research
February 2, 2012Pharma defeats biotech push for rapid approval program
February 2, 2012UPDATED: AstraZeneca cutting 2,200 R&D jobs, slashing neuroscience in restructuring
February 1, 2012Merrimack Pharma scraps IPO
February 1, 2012Investigators tout promising breast cancer vax data from small study
February 1, 2012Sangamo spikes on $13M discovery pact with Shire